Association Study of Val66Met Polymorphism in Brain-Derived Neurotrophic Factor Gene with Clozapine-Induced Metabolic Syndrome: Preliminary Results

The prevalence of the metabolic syndrome (MetS) is higher among patients receiving atypical antipsychotics (AAPs) treatment, and even among AAPs, treatment with clozapine has been shown to be associated with a higher long-term incidence rate of MetS. Likewise, brain-derived neurotrophic factor (BDNF...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Chen, Meijuan, Wu, Zhiguo, Chen, Jun, Yu, Shunying, Fang, Yiru, Zhang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742721/
https://www.ncbi.nlm.nih.gov/pubmed/23967328
http://dx.doi.org/10.1371/journal.pone.0072652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742721/
https://www.ncbi.nlm.nih.gov/pubmed/23967328
http://dx.doi.org/10.1371/journal.pone.0072652

Ejemplares similares